当前位置:首页 - 行情中心 - 安科生物(300009) - 财务分析

安科生物

(300009)

  

流通市值:119.62亿  总市值:165.00亿
流通股本:12.16亿   总股本:16.77亿

安科生物(300009)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润8.59亿元,每股收益0.51元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益393233.19万元,未分配利润139776.96万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产495076.05万元,负债101842.86万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入2,865,752,059.952,021,384,056.691,287,279,354.46594,174,209.84
营业总成本1,930,498,177.721,257,752,219.43826,263,354.01377,413,240.03
营业利润923,979,111.22768,473,455.84463,615,476.94219,909,981.02
利润总额919,929,605.88767,775,513.1463,508,351.45219,863,873.07
净利润858,588,991.57664,620,477.53401,863,500.55188,850,882.44
其他综合收益----
综合收益总额858,588,991.57664,620,477.53401,863,500.55188,850,882.44
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计2,325,483,458.752,090,507,909.851,854,095,806.782,114,109,026.09
非流动资产合计2,625,277,027.292,500,725,411.972,398,468,881.222,366,219,981.96
资产总计4,950,760,486.044,591,233,321.824,252,564,6884,480,329,008.05
流动负债合计847,080,888.86685,340,135.13645,144,834.82684,423,592.38
非流动负债合计171,347,690.88182,192,046.29178,373,891.43173,647,090.22
负债合计1,018,428,579.74867,532,181.42823,518,726.25858,070,682.6
归属于母公司股东权益合计3,737,399,547.013,522,940,262.13,240,264,828.53,419,565,300.37
股东权益合计3,932,331,906.33,723,701,140.43,429,045,961.753,622,258,325.45
负债和股东权益合计4,950,760,486.044,591,233,321.824,252,564,6884,480,329,008.05
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计2,567,892,245.451,903,924,209.881,183,476,049.11558,257,243.14
经营活动现金流出小计1,614,921,345.871,278,094,655.22850,576,488.68342,274,798.56
经营活动产生的现金流量净额952,970,899.58625,829,554.66332,899,560.43215,982,444.58
投资活动现金流入小计872,931,734.08738,950,870.26763,110,310.54747,025,938.88
投资活动现金流出小计1,490,203,341.361,038,727,693.18752,710,744.94920,356,399.38
投资活动产生的现金流量净额-617,271,607.28-299,776,822.9210,399,565.6-173,330,460.5
筹资活动现金流入小计41,057,57622,010,00010,000,00010,000,000
筹资活动现金流出小计442,051,672.55427,815,654.59423,950,254.893,588,440.85
筹资活动产生的现金流量净额-400,994,096.55-405,805,654.59-413,950,254.896,411,559.15
汇率变动对现金及现金等价物的影响-107,327.13-310,829.81-79,474.37-32,714.02
现金及现金等价物净增加额-65,402,131.38-80,063,752.66-70,730,603.2349,030,829.21
期末现金及现金等价物余额258,783,949.74244,122,328.46253,455,477.89373,216,910.33
最新报告期:2024-04-09
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
华鑫证券吴景欢,胡博新0.640.811.012024-04-09
国金证券袁维0.640.811.012024-03-27
广发证券罗佳荣0.680.85--2024-03-12
国金证券袁维0.670.83--2024-03-09
西南证券杜向阳0.620.77--2024-03-07
TOP↑